I help biotech and life sciences companies turn strategic ambitions into measurable business value by connecting business strategy, investment decisions and organisational readiness.
Whether you are evolving your business model, redesigning your operating model, transforming your IT architecture or preparing your organisation for the next stage of growth, I provide hands-on executive advisory to define what needs to change, prioritise where to invest, and ensure your organisation is ready to deliver.
My focus is on making transformation practical, proportionate and financially sound — achieving meaningful change without unnecessary investment, complexity or overhead.
For biotech founders, leadership teams and investors.
Where management consulting meets the business.
I support biotech challenges
Is your biotech company ready for change — but determined to invest wisely?
Whether you are scaling operations, rethinking your business model, modernizing your IT architecture, or preparing for your next stage of growth, every strategic decision matters.
In a capital-intensive industry, transformation should not mean spending more — it should mean investing smarter, avoiding costly mistakes, and building capabilities that deliver measurable business value.
I help biotech companies navigate complex transformation, align business and technology strategies, and turn investment decisions into sustainable growth.
01 / PRIORITIES
Are you investing in the right priorities?
02 / VALUE
Will your business case translate into realised value?
03 / SCALE
Is your operating model ready for the next stage of growth?
04 / DELIVERY
Do you have the governance and accountability to execute?
Choose focused support for investment decisions, portfolio priorities, operating models or growth—or ongoing fractional executive advisory.
Investment-to-Impact Diagnostic
Identify gaps between strategic priorities, investment decisions and execution. Establish the actions that can make the greatest difference.
3–5 man-days
Business Case & Value Realisation
Strengthen assumptions, clarify benefit ownership and establish practical ways to track and realise expected value.
5–10 man-days
Portfolio Prioritisation
Make trade-offs visible, compare competing initiatives and direct resources towards the highest-value opportunities.
5–8 man-days
Operating Model & Scale-up
Align decision rights, governance, capabilities and ways of working with the organisation’s next stage of growth.
10–20 man-days
Fractional Executive Advisor
Provide experienced senior-level challenge and ongoing support for strategic decisions, transformation and performance.
2–4 man-days / month
Growth & Investor Readiness
Assess alignment between growth plans, operating capabilities, governance and upcoming business milestones.
5–10 man-days
Indicative advisory effort; scope and timing agreed before engagement.
You may be looking for support when your company needs to:
Why to work with me?
You work directly with an experienced international transformation and investment leader. No layers of consultants, oversized programmes or unnecessary overhead. Just personal involvement, senior-level expertise and solutions proportionate to your business needs.
Build the business behind the science.
FOR INVESTORS & BOARDS
Turn investment into measurable business value.
Executive experience
Irena Prášilová brings more than 25 years of experience across MSD and Accenture, working at the intersection of finance, investment governance, portfolio leadership and organisational transformation.
Her work has involved complex investment decisions, operating-model changes, multinational teams and the challenge of translating strategic priorities into measurable outcomes.
Through Prasilova Advisory, she brings that executive perspective to biotech and life sciences companies and their investors.
Figures below describe previous portfolio and budget responsibilities; they are not biotech-specific performance claims.
$300M
Technology investment portfolio managed
$200M
Annual Opex stewardship
$100M
Annual Capex stewardship
90
People in teams led
How I work
Advisory should make complex decisions clearer and leave leadership teams better equipped to act.
01. Clarify what matters
Understand the business context, strategic choices and the outcomes that matter most.
02. Align decisions and ownership
Connect priorities, resources, governance and clear accountability for delivery.
03. Focus on realised value
Establish practical measures and review mechanisms to keep progress visible.
what i do Beyond advisory
Two passions run alongside my advisory work: sharing knowledge on conference stages and helping people make better decisions, build confidence and navigate their careers in a supportive environment.
Speaking & knowledge sharing
Turning experience into insight.
I speak at conferences and professional forums about portfolio decision-making, prioritisation, transformation and turning investment into measurable value. I value the exchange of experience—sharing practical lessons, asking better questions and learning from others across industries.
Mentoring & women’s development
Helping people make better decisions—and learn safely.
Mentoring is a personal passion: creating space for people to reflect, test ideas, learn from experience and make career decisions with greater confidence. I especially enjoy supporting women as they develop their voice, recognise their strengths and navigate professional challenges.
Mentoring communities: Odyssey (Czech), Equilibrium by BCC and Together2Grow.
Start a conversation
Whether you are building a biotech company, preparing for the next stage of growth or supporting a portfolio company, let’s discuss the challenge you are facing.
Email Irena ↗

